Latest News and Press Releases
Want to stay updated on the latest news?
-
Periodemeddelelse for 1. kvartal 2025/26 (1. juli - 30. september 2025) Vækst i omsætning og driftsresultat Omsætningen steg i 1. kvartal 2025/26 med 8% (11% ved faste valutakurser) til DKK 124,6...
-
Trading statement for Q1 2025/26 (1 July - 30 September 2025) Growth in revenue and operating profit Revenue was up by 8% in Q1 2025/26 (11% at constant exchange rates) to DKK 124.6 million from DKK...
-
MEDDELELSE NR. 295 28. oktober 2025 Opjustering ChemoMetec oplever en stigende interesse for sin teknologi, herunder ikke mindst XcytoMatic platformen, og forventer som følge heraf en positiv...
-
ANNOUNCEMENT NO. 295 28 October 2025 Upgrade of guidance ChemoMetec experiences an increased interest in its technology, not the least the XcytoMatic platform, and consequently expects a positive...
-
MEDDELELSE NR. 294 9. oktober 2025 Forløb af ordinær generalforsamling Den ordinære generalforsamling i ChemoMetec A/S blev afholdt den 9. oktober 2025 kl. 17.30 hos Nordsjællands...
-
ANNOUNCEMENT NO. 294 9 October 2025 Procedure of the Annual General Meeting The Annual General Meeting of ChemoMetec A/S was held on 9 October 2025 at 5.30 p.m. at Nordsjællands...
-
MEDDELELSE NR. 293 17. september 2025 Indkaldelse til ordinær generalforsamling Vedlagt offentliggøres selskabets indkaldelse til ordinær generalforsamling, som afholdes torsdag den 9. oktober...
-
ANNOUNCEMENT NO. 293 17 September 2025 Notice of Annual General Meeting Notice is hereby given of the Annual General Meeting, which will be held on Thursday 9 October 2025 at 5.30 p.m. The...
-
MEDDELELSE NR. 292 11. september 2025 Årsrapport 2024/25 (1. juli 2024 - 30. juni 2025) Vækst i omsætning og EBITDA ChemoMetecs omsætning steg i 2024/25 med 22% til DKK 495,6 mio., og...
-
ANNOUNCEMENT NO. 292 11 September 2025 Annual Report 2024/25 (1 July 2024 - 30 June 2025) Growing revenue and EBITDA ChemoMetec’s revenue grew by 22% to DKK 495.6 million in 2024/25, and...